Correlation Between Cadrenal Therapeutics, and Oncorus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Oncorus, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Oncorus.

Diversification Opportunities for Cadrenal Therapeutics, and Oncorus

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cadrenal and Oncorus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Oncorus go up and down completely randomly.

Pair Corralation between Cadrenal Therapeutics, and Oncorus

If you would invest  795.00  in Cadrenal Therapeutics, Common on September 2, 2024 and sell it today you would earn a total of  724.00  from holding Cadrenal Therapeutics, Common or generate 91.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy1.56%
ValuesDaily Returns

Cadrenal Therapeutics, Common  vs.  Oncorus

 Performance 
       Timeline  
Cadrenal Therapeutics, 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.
Oncorus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Cadrenal Therapeutics, and Oncorus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cadrenal Therapeutics, and Oncorus

The main advantage of trading using opposite Cadrenal Therapeutics, and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.
The idea behind Cadrenal Therapeutics, Common and Oncorus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance